Reduction of neutralization antibody against heterologous circulating strains in adults immunized with Japanese encephalitis live vaccine

Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain

(2013) Arindam Sarkar et al.   BMC INFECTIOUS DISEASES

Recurrence of Japanese Encephalitis Epidemic in Wuhan, China, 2009–2010

(2013) Quan Hu et al.   PLoS One

Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes

(2012) Elina O. Erra et al.   CLINICAL INFECTIOUS DISEASES

Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine

(2012) Yi-Chin Fan et al.   PLoS Neglected Tropical Diseases

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

(2012) S. Kyle Austin et al.   PLoS Pathogens

Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia

(2011) X.-L. Pan et al.   JOURNAL OF VIROLOGY

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China

(2011) Xinyu Liu et al.   VACCINE

Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3

(2010) James D. Brien et al.   JOURNAL OF VIROLOGY

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

(2010) Yongxin Yu   VACCINE

Effectiveness of One Dose of SA 14-14-2 Vaccine against Japanese Encephalitis

(2009) Rashmi Kumar et al.   NEW ENGLAND JOURNAL OF MEDICINE